
DiagnosTear Announces Frankfurt Stock Exchange Listing and Corporate Awareness Agreement
DiagnosTear Announces Frankfurt Stock Exchange Listing and Corporate Awareness Agreement

DiagnosTear Announces Frankfurt Stock Exchange Listing and Corporate Awareness Agreement
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
Appili Therapeutics to Attend BARDA Innovation Symposium 2025
FendX Files Provisional Patent for Novel Antimicrobial Nanoparticle Liquid Coating
BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES
Pangea Natural develops new peptide patch
XORTX Therapeutics prices $1.1M (U.S.) direct offering
Rocket Doctor AI adds U.S. insurer partners
Briacell adds three sites to Bria-IMT phase 3 study
Cardiol closes $11.4-million (U.S.) financing
Briacell, MSK to work on Bria-OTS+ clinical development
Tempramed arranges $2.5-million private placement
Satellos's SAT-3247 follow-up study doses first patient
Bionxt begins BNT23001 animal bioequivalence study
Amino Innovations Develops Next-Generation Peptide Patch Platform to Redefine Everyday Wellness